LYON, France, November 19, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a moderated scientific presentation of clinical data comparing Focal ...

HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatments Positive study results are expected to drive further ...

Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS SA (Nasdaq: ...

EDAP management highlighted what it sees as a growing global opportunity for therapeutic ultrasound in urology, emphasizing ...

Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery “The comparative results from these two cohorts ...

Efficacy and safety of a combination of sintilimab, bevacizumab plus gemcitabine, and albumin-bound paclitaxel for initially unresectable gallbladder carcinoma: A prospective, single-arm phase II ...

One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...

The Fred Hutchinson Cancer Center recently added irreversible electroporation (IRE) to its slate of focal therapy offerings and is the only cancer center in the region to offer IRE, high-intensity ...

The first prostate ablation treatment with the Ablatherm Robotic HIFU was performed at the Gramercy Surgery Center in New York. 1. Ivan Grunberger, MD, chief of urology at New York Methodist Hospital ...

New Haven Conn. (WTNH) –“CT BUZZ” Reporter Jillian Andrews recently spoke with Zion Zibly, MD, a Neurological Surgeon at Greenwich Hospital, who explained a procedure called High Intensity Focused ...